Abstract:OBJECTIVEGraves' disease (GD) is an organ-specific autoimmune disorder. Both immune-modulating genes and thyroid-specific genes are involved in its genetic pathogenesis. It remains unclear, however, how the interactions of various susceptibility genes contribute to the pathogenesis and clinical severity of the disease. The purpose of this study was to investigate the relationships between GD and single nucleotide polymorphisms (SNPs) from CTLA-4, PTPN22, PTPN12, FCRL3 (general autoimmunity genes regulating T and B cells) and the TSHR and Tg genes (disease-specific genes). Furthermore, we evaluated the influences these SNPs have on the risk and severity of GD.DESIGN AND METHODSThis cross-sectional clinical study was performed in 436 GD patients and 316 healthy, gender-matched individuals. Twenty-eight SNPs from CTLA-4, PTPN22, PTPN12, FCRL3, TSHR and Tg genes were genotyped and their associations with the risk and severity of GD were analysed.RESULTSThe CTLA-4 rs231779, Tg rs2069550 and PTPN22 rs3789604 SNPs were associated with GD, with additive risk effects present in rs231779 and rs2069550. The ACACC and ACGCT haplotypes, composed of five SNPs in the CTLA-4 gene (rs4553808, rs5472909, rs231775, rs231777 and rs231779), were protective and risk haplotypes respectively. The AA genotype of PTPN22 rs3789604 and AA genotype of FCRL3 rs7528684 were correlated with a reduced risk of GD, while the CC genotype of TSHR rs2239610 was associated with higher serum concentrations of FT4 and TRAb. Logistic analysis confirmed the contribution of CTLA-4 rs231779 to the development of GD.CONCLUSIONSThese preliminary results demonstrate that the immune-regulatory gene CTLA-4 and the thyroid-specific gene Tg contribute to the risk of Graves' disease with additive effects, while PTPN22 rs3789604 and FCRL3 rs7528684 polymorphisms are protective against the disease. In addition, the TSHR rs2239610 SNP is related to the severity of Graves' disease.

Pooled Genome Wide Association Detects Association Upstream of FCRL3 with Graves’ Disease

A Refined Study of FCRL Genes from a Genome-Wide Association Study for Graves' Disease.

An X chromosome-wide association analysis identifies variants in GPR174 as a risk factor for Graves' disease.

Association of 4p14 and 6q27 Variation with Graves Disease: a Case–control Study and a Meta-Analysis of Available Evidence

Genetic Study of Early-Onset Graves' Disease in the Chinese Han Population

Functional SNPs in the SCGB3A2 Promoter Are Associated with Susceptibility to Graves' Disease

Genome-wide scan of Graves' disease: evidence for linkage on chromosome 5q31 in Chinese Han pedigrees.

Recent Progress in Identification of Candidate Genes of Graves' Disease

Polymorphisms in the interleukin 3 gene show strong association with susceptibility to Graves’ disease in Chinese population

A Weighted Genetic Risk Score Using Known Susceptibility Variants to Predict Graves Disease Risk

Robust Evidence for Five New Graves' Disease Risk Loci from a Staged Genome-Wide Association Analysis

Genetic Study in a Large Cohort Supported Different Pathogenesis of Graves' Disease and Hashimoto's Hypothyroidism

Clinical Associations of the Genetic Variants of CTLA-4, Tg, TSHR, PTPN22, PTPN12 and FCRL3 in Patients with Graves' Disease.

Analysis of HLA Variants and Graves’ Disease and Its Comorbidities Using a High Resolution Imputation System to Examine Electronic Medical Health Records

Fine Mapping of Thyroglobulin Gene Identifies Two Independent Risk Loci for Graves’ Disease in Chinese Han Population

Identification of BACH2 as a susceptibility gene for Graves’ disease in the Chinese Han population based on a three-stage genome-wide association study

Association of the Rs6832151 Within Chromosomal Band 4p14 with Graves′disease

Compelling Evidence Linking CD40 Gene With Graves’ Disease in the Chinese Han Population

Genetic Heterogeneity Of Susceptibility Gene In Different Ethnic Populations: Refining Association Study Of Ptpn22 For Graves' Disease In A Chinese Han Population

Association Analysis of Single Nucleotide Polymorphisms in C1QTNF6, RAC2, and an Intergenic Region at 14q32.2 with Graves' Disease in Chinese Han Population

SCGB3A2: A Validated Susceptibility Gene to Graves' Disease in Different Ethnic Populations